Gilead Sciences (GILD) closed the most recent trading day at $69.94, moving +0.75% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.15%. On the other hand, the Dow registered a loss of 0.02%, and the technology-centric Nasdaq increased by 0.32%. Prior to today's trading, shares of the HIV and hepatitis C drugmaker had lost 7.83% over the past month. This has lagged the Medical sector's loss of 4.03% and the S&P 500's gain of 1.65% in that time. Investors will be eagerly wa ...